Study of a new generic cyclosporine, Consupren, in de novo renal transplant recipients

By Zafar M.N.   Ahmed E.   Alam A.   Akhtar F.   Zafar H.   Hashmi A.   Naqvi A.   Rizvi A.  

Transplantation Proceedings, Vol. 34, Iss. 6, 2002-09 ,pp. : 2480-2481

Elsevier

Access to resources Recommend Favorite

De novo breast cancer in renal transplant recipients

By Buell J.F.   Hanaway M.J.   Trofe J.   Gross T.G.   Beebe T.M.   Alloway R.R.   First M.R.   Woodle E.S.  

Transplantation Proceedings, Vol. 34, Iss. 5, 2002-08 ,pp. : 1778-1779

Elsevier

Access to resources Recommend Favorite

Tacrolimus-Basiliximab versus Cyclosporine-Basiliximab in renal transplantation ''de novo'': acute rejection and complications

By Garcia D.M.   Gago J.M.   Mendiluce A.   Gordillo R.   Bustamente J.  

Transplantation Proceedings, Vol. 35, Iss. 5, 2003-08 ,pp. : 1694-1696

Elsevier

Access to resources Recommend Favorite

Basiliximab-sirolimus-prednisone induction regimen followed by delayed low-dose cyclosporine in renal transplant recipients of living donors

By Langer R.M.   Hong D.M.   Katz S.M.   Van Buren C.T.  

Transplantation Proceedings, Vol. 34, Iss. 8, 2002-12 ,pp. : 3162-3164

Elsevier

Access to resources Recommend Favorite

Optimization of cyclosporine exposure utilizing C 2 level monitoring in de novo renal transplant recipients: the toronto general hospital experience

By Maham N.   Cardella C.   Cattran D.   Fenton S.   O'Grady C.   Hamill J.   Smith R.   Cole E.   Multi-Organ Transplant Program  

Transplantation Proceedings, Vol. 33, Iss. 7, 2001-11 ,pp. : 3098-3099

Elsevier

Access to resources Recommend Favorite